Articles
30 September 2025

Is the obesity paradox present in left ventricular assist device recipients? A BMI-based analysis

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
20
Views
79
Downloads

Authors

While body mass index (BMI) is a known determinant of cardiovascular outcomes, its impact on patients undergoing left ventricular assist device (LVAD) implantation remains unclear. This study aimed to evaluate the association between BMI and in-hospital outcomes in LVAD recipients. We conducted a retrospective, cross-sectional analysis using the National Inpatient Sample (2016-2020), identifying adult hospitalizations for LVAD implantation. Patients were categorized into six BMI groups. Outcomes assessed included in-hospital mortality, acute stroke, pump thrombosis, LVAD infection, length of stay (LOS), and hospital costs. Multivariable logistic regression adjusted for demographic, clinical, and hospital-level confounders, to estimate adjusted odds ratios (ORs) and beta (β) coefficients. Among 25,250 weighted admissions, 29.3% were females, with a median age of 63 years (IQR: 52-71). Class III obesity (BMI ≥40 kg/m2) accounted for the largest proportion (32.1%). The highest mortality rate was observed in the underweight group (6.7%), and class III obesity (5.8%) groups, while the lowest rate was noted in the class II obesity group (2.5%). Overall, a reverse J-shaped relationship between BMI and in-hospital mortality was observed. Compared to normal BMI, Class I (OR: 2.46; p=0.038), Class II (OR: 3.73; p=0.017), and Class III obesity (OR: 6.80; p<0.001) were significantly associated with increased odds of in-hospital mortality. Class III obesity was also associated with significantly prolonged LOS (β: 7.07 days; p=0.002) and higher hospital costs (β: $208,791.5; p=0.001). Overweight patients (BMI 25-29.9 kg/m2) had significantly lower odds of acute stroke (OR: 0.40; p=0.030), while no BMI group showed a significant association with pump thrombosis and LVAD infection. Higher BMI, particularly Class III obesity, is independently associated with increased mortality, length of stay, and hospital costs in LVAD recipients. These findings challenge the obesity paradox and underscore the need for refined risk stratification in this population.

Altmetrics

Downloads

Download data is not yet available.

Citations

1. World Health Organization. Obesity and overweight. Accessed: April 15, 2025. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
2. ABC News [Internet]. Obesity prevalence among US adults falls slightly to 40%, remains higher than 10 years ago: CDC - ABC News. Accessed: April 15, 2025. Available from: https://abcnews.go.com/Health/obesity-prevalence-us-adults-falls-slightly-40-remains/story?id=113927451
3. Koliaki C, Liatis S, Kokkinos A. Obesity and cardiovascular disease: revisiting an old relationship. Metabolism 2019;92:98-107. DOI: https://doi.org/10.1016/j.metabol.2018.10.011
4. Jin J. Obesity and the Heart. JAMA Network. Accessed: April 15, 2025. Available from: https://jamanetwork.com/journals/jama/fullarticle/1779537
5. Fioretti F, Lindman BR, Butler J. Biological plausibility and implications of obesity associated valvular heart diseases. Global Cardiology 2024;2:49 DOI: https://doi.org/10.4081/cardio.2024.49
6. Stanfor Medicine [Internet]. Left ventricular assist device. Accessed: April 15, 2025. Available from: https://stanfordhealthcare.org/medical-treatments/l/lvad.html
7. O’Horo JC, Abu Saleh OM, Stulak JM, et al. Left ventricular assist device infections: a systematic review. ASAIO J 2018;64:287-94. DOI: https://doi.org/10.1097/MAT.0000000000000684
8. Desai R, Li A, Mondal A, et al. In-hospital outcomes in metabolically healthy and unhealthy individuals over 65 years of age with obesity undergoing percutaneous intervention for acute coronary syndrome: A nationwide propensity-matched analysis (2016-2020). Obes Pillars 2024;11:100114. DOI: https://doi.org/10.1016/j.obpill.2024.100114
9. Powell-Wiley TM, Poirier CP, Burke VCLE, et al. Obesity and cardiovascular disease. Circulation 2021;143:e984-e1010. DOI: https://doi.org/10.1161/CIR.0000000000000973
10. Butler J, Howser R, Portner PM, Pierson RN. Body mass index and outcomes after left ventricular assist device placement. Ann Thorac Surg 2005;79:66-73. DOI: https://doi.org/10.1016/j.athoracsur.2004.06.047
11. Galand V, Flécher E, Lelong B, et al. Relation of body mass index to outcomes in patients with heart failure implanted with left ventricular assist devices. Am J Cardiol 2020;133:81-8. DOI: https://doi.org/10.1016/j.amjcard.2020.07.045
12. Yost G, Coyle L, Gallagher C, et al. The impact of extreme obesity on outcomes after left ventricular assist device implantation. J Thorac Dis 2017;9:4441-6. DOI: https://doi.org/10.21037/jtd.2017.10.52
13. HCUP Databases. Healthcare Cost and Utilization Project (HCUP) [Internet]. HCUP-US NIS Overview. Accesse:d July 15, 2024. Available from: https://hcup-us.ahrq.gov/nisoverview.jsp
14. Salman A, Saad M, Batool RM, et al. Obesity paradox in coronary artery disease: national inpatient sample analysis. Coron Artery Dis 2025;36:294-302. DOI: https://doi.org/10.1097/MCA.0000000000001479
15. Sreenivasan J, Lloji A, Khan MS, et al. Impact of body mass index on mortality in hospitalized patients with hypertrophic cardiomyopathy. Am J Cardiol 2022;175:106-9. DOI: https://doi.org/10.1016/j.amjcard.2022.04.011
16. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998;36:8-27. DOI: https://doi.org/10.1097/00005650-199801000-00004
17. Zahr F, Genovese E, Mathier M, et al. Obese patients and mechanical circulatory support: weight loss, adverse events, and outcomes. Ann Thorac Surg 2011;92:1420-6. DOI: https://doi.org/10.1016/j.athoracsur.2011.05.085
18. Musci M, Loforte A, Potapov EV, et al. Body mass index and outcome after ventricular assist device placement. Ann Thorac Surg 2008;86:1236-42. DOI: https://doi.org/10.1016/j.athoracsur.2008.05.044
19. Rosano GMC. Clinical trial design, endpoints and regulatory considerations in heart failure. Global Cardiology 2024;2:18. DOI: https://doi.org/10.4081/cardio.2024.18
20. Zhigalov K, Sá MPBO, Arjomandi Rad A, et al. The impact of obesity on left ventricular assist device outcomes. Medicina (Kaunas) 2020;56:556. DOI: https://doi.org/10.3390/medicina56110556
21. Clerkin KJ, Naka Y, Mancini DM, et al. The impact of obesity on patients bridged to transplantation with continuous-flow left ventricular assist devices. JACC Heart Fail 2016;4:761-8. DOI: https://doi.org/10.1016/j.jchf.2016.05.010
22. Go PH, Nemeh HW, Borgi J, et al. Effect of body mass index on outcomes in left ventricular assist device recipients. J Card Surg 2016;31:242-7. DOI: https://doi.org/10.1111/jocs.12702
23. Volkovicher N, Kurihara C, Critsinelis A, et al. Outcomes in patients with advanced heart failure and small body size undergoing continuous-flow left ventricular assist device implantation. J Artif Organs 2018;21:31-8. DOI: https://doi.org/10.1007/s10047-017-0988-z
24. Khan MS, Yuzefpolskaya M, Memon MM, et al. Outcomes Associated with obesity in patients undergoing left ventricular assist device implantation: a systematic review and meta-analysis. ASAIO J 2020;66:401-8. DOI: https://doi.org/10.1097/MAT.0000000000001019
25. Saeed D, Feldman D, Banayosy AE, et al. The 2023 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: a 10-year update. J Heart Lung Transplant 2023;42:e1-e222.
26. Boyle AJ, Jorde UP, Sun B, et al. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients. J Am Coll Cardiol 2014;63:880-8. DOI: https://doi.org/10.1016/j.jacc.2013.08.1656
27. Bryan CS, Yarbrough WM. Preventing deep wound infection after coronary artery bypass grafting: a review. Tex Heart Inst J 2013;40:125-39.
28. Huttunen R, Syrjänen J. Obesity and the risk and outcome of infection. Int J Obes (Lond) 2013;37:333-40. DOI: https://doi.org/10.1038/ijo.2012.62
29. Kuznetsova LA, Iavorovskiĭ AG, Petunina NA, et al. [Predictive value of body mass index for perioperative hyperglycemia occurrence in cardio-surgical patients without diabetes mellitus]. Anesteziol Reanimatol 2014;11-13.
30. Wang ZJ, Zhou YJ, Galper BZ, et al. Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysis. Heart 2015;101:1631-8. DOI: https://doi.org/10.1136/heartjnl-2014-307119
31. Horwich TB, Fonarow GC, Clark AL. Obesity and the obesity paradox in heart failure. Prog Cardiovasc Dis 2018;61:151-6. DOI: https://doi.org/10.1016/j.pcad.2018.05.005
32. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009;53:1925-32. DOI: https://doi.org/10.1016/j.jacc.2008.12.068
33. Mehra MR, Uber PA, Park MH, et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 2004;43:1590-5. DOI: https://doi.org/10.1016/j.jacc.2003.10.066
34. Brida M, Dimopoulos K, Kempny A, et al. Body mass index in adult congenital heart disease. Heart 2017;103:1250-7. DOI: https://doi.org/10.1136/heartjnl-2016-310571
35. Pocock SJ, McMurray JJV, Dobson J, et al. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J 2008;29:2641-50. DOI: https://doi.org/10.1093/eurheartj/ehn420
36. Flegal KM, Ioannidis JPA. The obesity paradox: a misleading term that should be abandoned. Obesity (Silver Spring) 2018;26:629-30. DOI: https://doi.org/10.1002/oby.22140
37. Banack HR, Kaufman JS. Does selection bias explain the obesity paradox among individuals with cardiovascular disease? Ann Epidemiol 2015;25:342-9. DOI: https://doi.org/10.1016/j.annepidem.2015.02.008
38. Sperrin M, Candlish J, Badrick E, et al. Collider bias is only a partial explanation for the obesity paradox. Epidemiology 2016;27:525-30. DOI: https://doi.org/10.1097/EDE.0000000000000493
39. Ovbiagele B, Bath PM, Cotton D, et al. Obesity and recurrent vascular risk after a recent ischemic stroke. Stroke 2011;42:3397-402. DOI: https://doi.org/10.1161/STROKEAHA.111.624957
40. Iikuni N, Lam QLK, Lu L, et al. Leptin and inflammation. Curr Immunol Rev 2008;4:70-9. DOI: https://doi.org/10.2174/157339508784325046
41. Oesch L, Tatlisumak T, Arnold M, Sarikaya H. Obesity paradox in stroke - Myth or reality? A systematic review. PLoS One 2017;12:e0171334. DOI: https://doi.org/10.1371/journal.pone.0171334
42. Parto P, Lavie CJ, Arena R, et al. Body habitus in heart failure: understanding the mechanisms and clinical significance of the obesity paradox. Future Cardiol 2016;12:639-53. DOI: https://doi.org/10.2217/fca-2016-0029
43. Samad F, Ruf W. Inflammation, obesity, and thrombosis. Blood 2013;122:3415-22. DOI: https://doi.org/10.1182/blood-2013-05-427708
44. Jaiswal A, Truby LK, Chichra A, et al. Impact of obesity on ventricular assist device outcomes. J Card Fail 2020;26:287-97. DOI: https://doi.org/10.1016/j.cardfail.2019.10.001
45. Blokhin IO, Lentz SR. Mechanisms of thrombosis in obesity. Curr Opin Hematol 2013;20:437-44. DOI: https://doi.org/10.1097/MOH.0b013e3283634443
46. McAuley PA, Artero EG, Sui X, et al. The obesity paradox, cardiorespiratory fitness, and coronary heart disease. Mayo Clin Proc 2012;87:443-51. DOI: https://doi.org/10.1016/j.mayocp.2012.01.013
47. Barry VW, Baruth M, Beets MW, et al. Fitness vs. fatness on all-cause mortality: a meta-analysis. Prog Cardiovasc Di. 2014;56:382-90. DOI: https://doi.org/10.1016/j.pcad.2013.09.002
48. de Koning L, Merchant AT, Pogue J, Anand SS. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J 2007;28:850:6. DOI: https://doi.org/10.1093/eurheartj/ehm026
49. Efremova E, Shutov A. Adherence to lifestyle therapy in patients with chronic heart failure and comorbidity. Global Cardiology 2023;1:8. DOI: https://doi.org/10.4081/cardio.2023.8

How to Cite



1.
Waqas SA, Siddiqui H, Kalle F, Hassan S. Is the obesity paradox present in left ventricular assist device recipients? A BMI-based analysis. Global Cardiol [Internet]. 2025 Sep. 30 [cited 2025 Oct. 5];3(3). Available from: https://www.globalcardiology.info/site/article/view/84

Share